Medicine

Hibernation scientific research took advantage of to manage being overweight and also tweak metabolism

.Attributes Medication, Posted online: 04 September 2024 doi:10.1038/ s41591-024-03226-wBy knowing t...

CAR- T and also cellular gene treatments are actually too pricey

.Mother Nature Medicine, Released online: 04 September 2024 doi:10.1038/ s41591-024-03231-zPoint-of-...

The WHO genomics course of benefit equitable execution of individual genomics for worldwide wellness

.The publication of the initial draft of the human genome series in 20011 was observed by the dawn o...

A time-stratified, case\u00e2 $ \"crossover research study of warm visibility and perinatal mortality from 16 hospitals in sub-Saharan Africa

.Among 138,015 hospital-based singleton childbirths in 4 sub-Saharan African nations, our experts no...

Advancing international antibiotic analysis, progression and also get access to #.\n\nMurray, C. J. L. et cetera. International problem of bacterial antimicrobial protection in 2019: a systematic review. Lancet 399, 629\u00e2 $ \"655 (2022 ). AMR Frontrunnerses. Towards particular dedications and action in the action to antimicrobial resistance. Global Leaders Group on Antimicrobial Protection https:\/\/www.amrleaders.org\/resources\/m\/item\/glg-report (4 April 2024). World Health Association. That posts list of germs for which new antibiotics are quickly required. World Health Organization https:\/\/www.who.int\/news\/item\/27-02-2017-who-publishes-list-of-bacteria-for-which-new-antibiotics-are-urgently-needed (27 February 2017). World Health Institution. WHO bacterial concern microorganisms listing, 2024: microbial virus of hygienics usefulness to lead research, development and also methods to stop and manage antimicrobial resistance. Planet Health Association https:\/\/www.who.int\/publications\/i\/item\/9789240093461 (17 May 2024). Silver, L. L. A Gestalt approach to Gram-negative entry. Bioorg. Medication. Chem. 24, 6379\u00e2 $ \"6389 (2016 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\n\nGoogle Scholar\u00c2.\nSundqvist, M. Reversibility of antibiotic resistance. Ups. J. Med. Sci. 119, 142\u00e2 $ \"148 (2014 ).\nGoogle.com Scholar\u00c2.\nWorld Health And Wellness Organization. 2023 antibacterial brokers in clinical as well as preclinical progression: an outline and review. Globe Health and wellness Institution https:\/\/www.who.int\/publications\/i\/item\/9789240094000 (14 June 2024). O' Neill, J. et cetera. AMR Evaluation. May 19, 2016 \u00e2 $\" Handling drug-resistant diseases worldwide: ultimate record and also suggestions. Testimonial on Antimicrobial Resistance https:\/\/amr-review.org\/Publications.html (19 May 2016). Drive-AB Range. DRIVE-AB results: documents and also rundown. Steer abdominal muscle https:\/\/drive-ab.eu\/drive-ab-outputs\/drive-ab-reports\/ (2016 ). Stern, S. et cetera. Appearing the wall: a call for collective activity on anti-biotics r &amp d. Boston ma Consulting Team https:\/\/www.bundesgesundheitsministerium.de\/fileadmin\/Dateien\/5_Publikationen\/Gesundheit\/Berichte\/GUARD_Follow_Up_Report_Full_Report_final.pdf (February, 2017). Anderson, M., Panteli, D. &amp Mossialos, E. Policy Concise 51: Exactly how can the EU support sustainable development and access to reliable antibiotics? plan possibilities for existing and also brand new medications. European Observatory on Health And Wellness Equipments and also Policies https:\/\/eurohealthobservatory.who.int\/publications\/i\/how-can-the-eu-support-sustainable-innovation-and-access-to-effective-antibiotics-policy-options-for-existing-and-new-medicines (21 June 2023). Turnidge, J. &amp Christiansen, K. Anti-biotic use and resistance\u00e2 $\" showing the apparent. Lancet 365, 548\u00e2 $ \"549 (2005 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle Scholar\u00c2.\nGlobe Health And Wellness Association. 2021 Knowledgeable category. That get access to, watch, book, category of anti-biotics for analysis as well as monitoring of utilization. World Wellness Company https:\/\/www.who.int\/publications\/i\/item\/2021-aware-classification (30 September 2021). European Center for Ailment Protection and Control. Antimicrobial protection targets: how can our team reach all of them through 2030? ECDC https:\/\/www.ecdc.europa.eu\/sites\/default\/files\/documents\/amr-brief-eaad-2023-update.pdf (2023 ). Globe Wellness Company. Absence of advancement set to weaken antibiotic efficiency as well as health and wellness increases. Globe Health Institution https:\/\/www.who.int\/news\/item\/22-06-2022-22-06-2022-lack-of-innovation-set-to-undermine-antibiotic-performance-and-health-gains (22 June 2022). Magnano San, L. R. et cetera. Exactly how antimicrobial protection is linked to environment change: a review of pair of entwined global challenges. Int. J. Environ. Res. Public Health 20, 1681 (2023 ). Article\u00c2.\n\nGoogle.com Scholar\u00c2.\nDolecek, C., Shakoor, S., Basnyat, B., Okwor, T. &amp Sartorius, B. Drug-resistant bacterial infections: we require important activity and also investment that concentrate on the weakest link. PLoS Biol. Twenty, e3001903 (2022 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle Scholar\u00c2.\nWorld Health And Wellness Company. Immunization coverage. Globe Wellness Institution https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/immunization-coverage (15 July 2024). Chimhini, G., Magwenzi, M. &amp Fitzgerald, F. C. Infection protection and also management in low-resource environments: the requirement for the neighborhood, the contextual as well as the pragmatic. Infect. Prev. Pract. 4, 100135 (2022 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\n\nGoogle Scholar\u00c2.\nNour, S., Stokle, E., Ashiru-Oredope, D. &amp Wesangulae, E. Challenges of applying antimicrobial stewardship resources in low to center revenue nations (LMICs). Affect. Prev. Pract. 5, 100315 (2023 ). Article\u00c2.\n\nGoogle.com Scholar\u00c2.\nAminov, R. A quick history of the antibiotic time: sessions knew and also problems for the future. Face. Microbiol. 1, 134 (2010 ). Article\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle Scholar\u00c2.\nOutterson, K. et cetera. Individual get access to in 14 high-income countries to brand-new antibacterials approved by the United States Food and Drug Administration, European Medicines Firm, Japanese Pharmaceuticals and Medical Devices Firm, or Wellness Canada, 2010\u00e2 $ \"2020. Clin. Affect. Dis. 74, 1183\u00e2 $ \"1190 (2022 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle Scholar\u00c2.\nGlobe Health And Wellness Association. 2021 anti-bacterial agents in scientific and preclinical growth: a guide as well as review. Planet Wellness Company https:\/\/www.who.int\/publications\/i\/item\/9789240047655 (27 May 2022). Antibiotics: the business economics have to assist the science. Attribute 625, 7 (2024 ). Thomas, D. &amp Wessel, C. The state of advancement in antibacterial therapeutics. Biotechnology Innovation Association https:\/\/www.bio.org\/sites\/default\/files\/2022-02\/The-State-of-Innovation-in-Antibacterial-Therapeutics.pdf (February, 2022). Strich, J. et al. Evaluating clinician usage of next-generation anti-biotics against immune Gram-negative diseases in U.S. healthcare facilities: a retrospective cohort research study. Ann. Trainee. Medication. 177, 559\u00e2 $ \"572 (2024 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle Scholar\u00c2.\nThomas, D. &amp Wessel, C. The state of development in antibacterial therapies. Biotechnology Technology Association https:\/\/www.bio.org\/sites\/default\/files\/2022-04\/BIO-Antibacterial-Report-2022.pdf (February 2022). Renwick, M. J., Brogan, D. M. &amp Mossialos, E. A systematic testimonial and critical evaluation of reward methods for revelation as well as advancement of unfamiliar anti-biotics. J. Antibiot. 69, 73\u00e2 $ \"88 (2016 ). Article\u00c2.\nCAS\u00c2.\n\nGoogle.com Scholar\u00c2.\nHealth Unexpected Emergency Readiness and also Reaction Authority. Research and development of health care countermeasures. International Compensation https:\/\/health.ec.europa.eu\/health-emergency-preparedness-and-response-hera\/preparedness\/research-and-development-medical-countermeasures_en (2024 ). European Payment. Pre-draft proposal for an International partnership under Perspective Europe One Wellness Antimicrobial Protection. International Compensation https:\/\/research-and-innovation.ec.europa.eu\/system\/files\/2022-02\/ec_rtd_he-partnerships-onehealth-amr.pdf (9 February 2022). Global Anti-biotic R &amp D Partnership. Entasis Therapeutics and the Worldwide Antibiotic Research &amp Progression Relationship to establish a brand-new procedure for gonorrhea. GARDP https:\/\/gardp.org\/entasis-therapeutics-and-the-global-antibiotic-research-development-partnership-to-develop-a-new-treatment-for-gonorrhea\/ (6 July 2017). Atal, I., Trinquart, L., Porcher, R. &amp Ravaud, P. Differential globalization of field- as well as non-industry-sponsored medical tests. PLoS ONE 10, e0145122 (2015 ). Article\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle Scholar\u00c2.\nGlobe Health And Wellness Company. Amount of scientific test registrations through area, disease, period of advancement, age and also sex of trial attendees (1999\u00e2 $ \"2022). Planet Health and wellness Organization https:\/\/www.who.int\/observatories\/global-observatory-on-health-research-and-development\/monitoring\/number-of-trial-registrations-by-year-location-disease-and-phase-of-development (February 2023). International Prescription Antibiotic Experimentation Relationship. NeoSept1: a research to calculate the position of existing as well as new anti-biotics combos to treat newborn babies that reside in healthcare facility along with extreme sepsis. ISRCTN computer registry https:\/\/www.isrctn.com\/ISRCTN48721236 (17 January 2022). Hygienics Agency of Canada. Authorities of Canada brings in important investment to fight antimicrobial resistance (AMR), Government of Canada https:\/\/www.canada.ca\/en\/public-health\/news\/2023\/05\/government-of-canada-makes-important-investment-to-fight-antimicrobial-resistance-amr.html (11 May 2023). Worldwide Prescription Antibiotic Research and Development Relationship. Asia authorities backing sustains GARDP\u00e2 $ s attempts to resist antibiotic protection. GARDP https:\/\/gardp.org\/japan-government-funding-supports-gardps-efforts-to-counter-antibiotic-resistance\/ (19 Oct 2023). Novo Nordisk Structure. Novo Nordisk Base companions with CARB-X to combat drug-resistant diseases. novo nordisk foundation https:\/\/novonordiskfonden.dk\/en\/news\/novo-nordisk-foundation-partners-with-carb-x-to-fight-drug-resistant-infections\/ (9 January 2024). International Commission: European Health and Digital Manager Company. Research on bringing AMR clinical countermeasures to the marketplace. Publications Workplace of the European Union https:\/\/op.europa.eu\/en\/publication-detail\/-\/publication\/51b2c82c-c21b-11ed-8912-01aa75ed71a1\/language-en (2023 ). Outterson, K. Estimating the proper size of global pull incentives for anti-bacterial medications. Wellness Aff. 40, 1758\u00e2 $ \"1765 (2021 ). Article\u00c2.\n\nGoogle Scholar\u00c2.\nEvans, E. J., Meyer, A. &amp Conti, R. M. Dimensions a market entrance incentive for the progression of brand-new anti-biotics. Harvard Kennedy School https:\/\/www.hks.harvard.edu\/sites\/default\/files\/centers\/mrcbg\/Final_AWP_232.pdf (May 2024). Morel, C. M. et al. Industry incentives and also antibiotic resistance: an intro to the antibiotic susceptibility bonus offer. J. Antibiot. 73, 421\u00e2 $ \"428 (2020 ). CAS\u00c2.\n\nGoogle Scholar\u00c2.\nBonnifield, R. &amp Towse, A. An eager USG evolved dedication for subscription-based getting of unique antimicrobials and its expected roi. Center for Global Progression https:\/\/www.cgdev.org\/publication\/ambitious-usg-advanced-commitment-subscription-based-purchasing-novel-antimicrobials (15 November 2022). Towse, A. &amp Silverman Bonnifield, R. G7 financial investments in brand new anti-biotics would certainly pay off \u00e2 $\" for every person. Workplace of Health and wellness Business economics https:\/\/www.ohe.org\/insight\/g7-investments-in-new-antibiotics-would-pay-off-for-everyone\/ (9 December 2022). NHS England. NHS steps up fight against severe contaminations observing successful world-first fly. NHS England https:\/\/www.england.nhs.uk\/2023\/07\/nhs-steps-up-battle-against-life-threatening-infections-following-successful-world-first-pilot\/ (11 July 2023). United States Congress. S. 1355 \u00e2 $\" PASTEUR Act of 2023. congress.gov www.congress.gov\/bill\/118th-congress\/senate-bill\/1355#:~:text=This%20bill%20authorizes%20the%20Department,and%20contains%20other%20related%20provisions (27 April 2023). European Compensation. Reform of the EU pharmaceutical legalisation. European Compensation https:\/\/health.ec.europa.eu\/medicinal-products\/pharmaceutical-strategy-europe\/reform-eu-pharmaceutical-legislation_en (26 April 2023). Gotham, D. et al. Reimbursement designs to tackle market breakdowns for antimicrobials: approaches enjoyed France, Germany, Sweden, the UK, as well as the USA. Health and wellness Plan 125, 296\u00e2 $ \"306 (2020 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle Scholar\u00c2.\nInternational Federation of Pharmaceutical Manufacturers and Associations. Coming from resistance to resilience: what could the future antibiotic pipeline appear like? IFMPA https:\/\/www.ifpma.org\/publications\/from-resistance-to-resilience-what-could-the-future-antibiotic-pipeline-look-like\/ (14 May 2024). International AMR R&ampD Hub &amp Planet Health And Wellness Company. Incentivising the progression of brand-new anti-bacterial therapies: 2023 progress report by the Global AMR R&ampD Center as well as WHO. Worldwide AMR R&ampD Hub https:\/\/globalamrhub.org\/publications\/incentivising-the-development-of-new-antibacterial-treatments-2023\/ (2023 ). Glover, R. E., Singer, A., Roberts, A. P. &amp Kirchhelle, C. Why is the UK subscription style for prescription antibiotics taken into consideration productive? Lancet Microbe 4, e852\u00e2 $ \"e853 (2023 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle.com Scholar\u00c2.\nNon-paper \u00e2 $\" unfamiliar stimulations for the development and also going on the market of antimicrobials. Politician https:\/\/www.politico.eu\/wp-content\/uploads\/2022\/12\/01\/Non-paper-Transferable-exclusivity-voucher-for-AMR-2.pdf (2022 ). Liu, L. et al. Global, regional, and also nationwide reasons for child death in 2000\u00e2 $ \"thirteen, along with estimates to inform post-2015 top priorities: an upgraded systematic review. Lancet 385, 430\u00e2 $ \"440 (2015 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle Scholar\u00c2.\nQuadri, F. et al. Anti-bacterial medicine scarcities from 2001 to 2013: implications for clinical training. Clin. Infect. Dis. 60, 1737\u00e2 $ \"1742 (2015 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle Scholar\u00c2.\nBenhabib, A. et al. The French coverage unit for medication scarcities: summary and also trends from 2012 to 2018: an observational retrospective study. BMJ Open 10, e034033 (2020 ). Article\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle Scholar\u00c2.\nKlein, E. Y. et cetera. Analysis of WHO antibiotic usage and gain access to targets in 76 countries, 2000\u00e2 $ \"15: an analysis of pharmaceutical sales records. Lancet Infect. Dis. 21, 107\u00e2 $ \"115 (2021 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle.com Scholar\u00c2.\nPyzik, O. Z. &amp Abubakar, I. Combating the counterfeits: taking on low quality and falsified medications. Nat. Rev. Dis. Guides 8, 55 (2022 ). Hayhoe, B., Greenfield, G. &amp Majeed, A. Is it getting much easier to secure prescription antibiotics in the UK? Br. J. Gen. Pract. 69, 54\u00e2 $ \"55 (2019 ). Article\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle.com Scholar\u00c2.\nBlack Community for Research Laboratory Medication. Plan short and also infographics on antimicrobial resistance (AMR) in Africa. ASLM https:\/\/aslm.org\/resource\/policy-brief-and-infographics-on-antimicrobial-resistance-amr-in-africa\/ (14 September 2022). Kanu, J. S. et cetera. National antibiotic usage for individual use in Sierra Leone (2017\u00e2 $ \"2019): a cross-sectional study. Trop. Medication. Corrupt. Dis. 6, 77 (2021 ). Article\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle Scholar\u00c2.\nNamugambe, J. S. et cetera. National antimicrobial usage: study of core storehouses materials to in-patient care health and wellness establishments from 2017 to 2019 in Uganda. Trop. Medication. Corrupt. Dis. 6, 83 (2021 ).\nGoogle Scholar\u00c2.\nRobertson, J. et cetera. Variants in the usage of antimicrobial medications in the European area, 2014\u00e2 $ \"2018: seekings and implications from ESAC-Net as well as WHO Europe. Front. Pharmacol. 12, 639207 (2021 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle.com Scholar\u00c2.\nShukar, S. et cetera. Medicine lack: triggers, impact, and also minimization strategies. Front end. Pharmacol. 12, 693426 (2021 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle.com Scholar\u00c2.\nOutterson, K., Orubu, E. S. F., Rex, J., \u00c3 ... rdal, C. &amp Zaman, M. H. Client get access to in 14 high-income nations to new antibacterials approved due to the United States Food and Drug Administration, European Medicines Firm, Japanese Pharmaceuticals and also Medical Equipment Organization, or even Wellness Canada, 2010\u00e2 $ \"2020. Clin. Corrupt. Dis. 74, 1183\u00e2 $ \"1190 (2021 ). Article\u00c2.\nPubMed Central\u00c2.\n\nGoogle.com Scholar\u00c2.\nPulcini, C. et cetera. Wasted prescription antibiotics: a follow-up supply study in Europe, the U.S.A., Canada and Australia. Int. J. Antimicrob. Agents 49, 98\u00e2 $ \"101 (2017 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\n\nGoogle Scholar\u00c2.\nRottingen, J. A. &amp Farrar, J. Targeted health and wellness technology for international health. Br. Medication. J. 366, 15601 (2019 ).\nGoogle.com Scholar\u00c2.\nAMR Sector Partnership. The 2023 AMR Sector Alliance improvement study: manufacturing and also the environment. amr Market Collaboration https:\/\/www.amrindustryalliance.org\/wp-content\/uploads\/2023\/12\/AMRIA_Manufacturing-and-the-environment-FINAL.pdf (2023 ). Munoz, V., Visentin, F., Foray, D. &amp Gaule, P. Can medical items be actually created on a charitable manner? Exploring item growth collaborations for disregarded conditions. Sci. Public law 42, 315\u00e2 $ \"338 (2015 ). Article\u00c2.\n\nGoogle.com Scholar\u00c2.\nSwaminathan, S. et al. Restart biomedical R&ampD in the worldwide social rate of interest. Attribute 602, 207\u00e2 $ \"210 (2022 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\n\nGoogle Scholar\u00c2.\nAfrica Centres for Ailment Control and Prevention. Africa CDC pioneers vibrant relocate to get Africa\u00e2 $ s wellness future through producing a fifty billion buck clinical market. AfricaCDC https:\/\/africacdc.org\/news-item\/africa-cdc-spearheads-bold-move-to-secure-africas-health-future-by-creating-a-50-billion-dollar-medical-market\/ (19 February 2024). Gore, C., Morin, S., R\u00c3 \u00b8 ttingen, J. A. &amp Kieny, M. P. Negotiating public-health trademark licensing arrangements to improve accessibility to wellness modern technologies: an insider\u00e2 $ s account. BMJ Glob. Wellness 8, e012964 (2023 ). Article\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle Scholar\u00c2.\nSuleman, F., Low, M., Moon, S. &amp Morgan, S. G. New business styles for r &amp d with cost needs are actually required to accomplish reasonable prices of medicines. Br. Med. J. 368, l4408 (2020 ). Article\u00c2.\n\nGoogle.com Scholar\u00c2.\nCombating Antibiotic-Resistant Micro-organisms Biopharmaceutical Gas. Conservation and access. CARB-X https:\/\/carb-x.org\/about\/stewardship-and-access\/ (2024 ). Worldwide Prescription Antibiotic Experimentation Relationship. Shinogi, GARDP as well as CHAI introduce site license as well as collaboration contracts to handle bacterial infections by broadening accessibility to cefiderocol in 135 countries. GARDP https:\/\/gardp.org\/shionogi-gardp-and-chai-announce-landmark-license-and-collaboration-agreements-to-treat-bacterial-infections-by-expanding-access-to-cefiderocol-in-135-countries\/ (15 June 2022). AMR Sector Alliance. Leaving the laboratory: tracking the downtrend in AMR R&ampD professionals. amr Business Alliance https:\/\/www.amrindustryalliance.org\/wp-content\/uploads\/2023\/02\/Leaving-the-Lab_final-1.pdf (February, 2024). G7 Health Ministers. G7 Health Ministers\u00e2 $ Communiqu\u00c3 \u00a9. G7 Germany www.g7germany.de\/resource\/blob\/974430\/2042058\/5651daa321517b089cdccfaffd1e37a1\/2022-05-20-g7-health-ministers-communique-data.pdf (twenty May 2022). G20. G20 phone call to action on antimicrobial resistance. G7G20 Files Database https:\/\/g7g20-documents.org\/database\/document\/2022-g20-indonesia-sherpa-track-health-ministers-ministers-annex-g20-call-to-action-on-antimicrobial-resistance (28 Oct 2022). Global Coalition on Getting Older &amp Transmittable Illness Culture of America. 2024 AMR preparedness index report card. Measuring authorities activity on AMR plan. Worldwide Union on Getting older https:\/\/globalcoalitiononaging.com\/wp-content\/uploads\/2024\/01\/2024-AMR-Index-Progress-Report.pdf (2024 ). Food Items and also Farming Association of the United Nations, United Nations Atmosphere Programme, Planet Wellness Organization &amp. Planet Organisation for Pet Wellness. Global data source for tracking antimicrobial protection (AMR): nation self-assessment questionnaire (TrACSS). That https:\/\/amrcountryprogress.org\/

/map-viewindicator2.3 (2023 ). Vehicle Katwyk, S. R. &amp Outterson K. Introduction: AMR belongs in ...

Integrating liver endpoints in scientific trials of cardio as well as kidney disease

.Nature Medicine, Published online: 03 September 2024 doi:10.1038/ s41591-024-03223-zThis Standpoint...

FALSE:: INACCURACY: UNSUPPORTED ENCODING...

Artificial intelligence led testing for cardiomyopathies in an obstetric populace: a pragmatic randomized professional test

.Test concept as well as oversightThe Testing for PEripartum Cardiomyopathies along with Artificial ...

Sustained HIV remission after allogeneic hematopoietic stalk cell hair transplant with wild-type CCR5 donor tissues

.Nature Medicine, Posted online: 02 September 2024 doi:10.1038/ s41591-024-03277-zHIV remission for ...

Senolytics target cellular senescence-- but can they decrease getting older?

.In the 1960s, United States anatomist Leonard Hayflick noticed that replicative tissues have a limi...